Junshi Biosciences, AsiaInfo Tech pre-market HK IPOs

By Jonathan Breen
29 Nov 2018

Shanghai Junshi Biosciences kicked off pre-deal investor education for its Hong Kong listing this week, following close behind Chinese telecommunications software provider AsiaInfo Technologies.

Junshi Biosciences, which develops drugs to treat auto-immune and metabolic diseases in China, is looking to raise around $500m, GlobalCapital Asia reported previously.

CICC is leading the IPO as sole sponsor and a global co-ordinator with Citi, China Securities International, Credit Suisse and Fosun Hani Securities.

Investor meetings will run ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial